The present invention relates to compounds of formulae IA and IB wherein
R.sup.1 and R.sup.2 are each independently lower alkyl or
--(CH.sub.2).sub.m--O-lower alkyl, or together with the N atom to which
they are attached form a heterocyclic ring; R.sup.3 is hydrogen or lower
alkyl; R.sup.4 is lower alkyl; hetaryl is 3H-imidazole-2,4-diyl or
1H-pyrazole-1,4-diyl; n is 1 or 2; and m is 1 or 2; and to
pharmaceutically acceptable acid addition salts thereof. These compounds
may be used for the treatment of Alzheimer's disease, Parkinson's
disease, Huntington's disease, neuroprotection, schizophrenia, anxiety,
pain, respiration deficits, depression, ADHD, drug addiction, such as
amphetamine, cocaine, opioids, ethanol, nicotine, cannabinoids, or for
the treatment of asthma, allergic responses, hypoxia, ischaemia, seizure
and substance abuse, or for use as sedatives, muscle relaxants,
antipsychotics, antiepileptics, anticonvulsants and cardiaprotective
agents for coronary artery disease and heart failure.